Copper complexes: a physiological approach to the treatment of ‘inflammatory diseases’
Authors:
- John R.J. SorensonJSJohn R.J. Sorenson
- Vimal KishoreVKVimal Kishore
- Abbas PezeshkAPAbbas Pezeshk
- Larry W. OberleyLOLarry W. Oberley
- Susan W.C. LeuthauserSLSusan W.C. Leuthauser
- Terry D. OberleyTOTerry D. Oberley
- 1 April 1984
- journal article
- Published by Elsevier in Inorganica Chimica Acta
- Vol. 91 (4) , 285-294
Abstract
No abstract availableThis publication has 46 references indexed in Scilit:
- Pharmacologic activities of copper compounds in chronic diseasesBiological Trace Element Research, 1983
- Testing for drugs inhibiting the formation of gastric ulcersJournal of Pharmacological Methods, 1982
- Protective role of ceruloplasmin in inflammationInflammation Research, 1979
- Adjuvant Arthritis in young copper-deficient ratsInflammation Research, 1978
- Carrageenan oedema in copper-deficient ratsInflammation Research, 1978
- Testing for the gastro-intestinal irritancy of aspirin and indomethacinJournal of Pharmacological Methods, 1978
- A study of copper treatment and tissue copper levels in the murine congenital copper deficiency, mottledLife Sciences, 1976
- The effect of tremorigenic substances on the copper content of the rat brainJournal of Neurochemistry, 1966
- Copper Metabolism and Epilepsy: A Preliminary ReportEpilepsia, 1966
- Der Eisen-Kupferantagonismus im Blutplasma beim InfektionsgeschehenJournal of Molecular Medicine, 1938